42Bio is a spinoff company developing and commercializing biomedical technologies from our laboratories at the University of Florida. The founders comprise a team of leading biotechnology scientists. While we may not have the answer to everything in the universe, we are actively engaged in seeking answers to questions about life to advance human and veterinary health.

42Bio has an expanding patent portfolio available through the University of Florida. Our patents have applications in skincare, regenerative medicine, and veterinarian medicine.  To learn more about our technologies, click on the links below.